IMC Chicago’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-39,978
Closed -$3.56M 5734
2025
Q4
$3.16M Buy
39,978
+14,019
+54% +$1.1M ﹤0.01% 2067
2025
Q3
$2.08M Buy
+25,959
New +$2.21M ﹤0.01% 2193
2025
Q1
Sell
-25,312
Closed -$2.27M 3160
2024
Q4
$2.3M Sell
25,312
-63,110
-71% -$6.02M ﹤0.01% 1760
2024
Q3
$9.18M Buy
88,422
+70,292
+388% +$7.16M 0.01% 860
2024
Q2
$1.76M Buy
18,130
+5,350
+42% +$494K ﹤0.01% 1636
2024
Q1
$1.15M Buy
+12,780
New +$1.08M ﹤0.01% 1662
2023
Q4
Sell
-10,343
Closed -$778K 1819
2023
Q3
$735K Buy
+10,343
New +$773K ﹤0.01% 1323

Other funds holding CL

IMC Chicago's CL Position: Q1 2026 in Review

IMC Chicago sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 39,978 shares — an estimated $3.56M sold.

IMC Chicago first reported a position in CL in Q3 2023 and held it in 7 quarters. The position peaked at $9.18M in Q3 2024. 1,954 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • IMC Chicago reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • IMC Chicago sold 39,978 Colgate-Palmolive shares in Q1 2026, an estimated $3.56M.
  • IMC Chicago first reported a position in Colgate-Palmolive in Q3 2023 and held it in 7 quarters.
  • IMC Chicago's Colgate-Palmolive position peaked at $9.18M in Q3 2024.
  • 1,954 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on IMC Chicago's 13F filing for Q1 2026, filed 5 May 2026.